BSE filing, NSE: KSL. Summary written from the filing by ALFA Finder's alert engine.
Kalyani Steels Ltd: key numbers
- Share price
- ₹822.95
- Market cap
- ₹3,592 Cr
- Revenue (annual)
- ₹1,846 Cr
- Net profit (annual)
- ₹257.9 Cr
- P/E (TTM)
- 12.8×Sector 16.5×
- Promoter holding
- 64.70%+0.00% QoQ
- FII holding
- 1.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kalyani Steels Ltd
All →Kalyani Steels Management Change
Amit Kalyani appointed Chairman of Kalyani Steels, succeeding Dr. Babasaheb Kalyani. The transition positions the company for growth in green steel and advanced materials.
Kalyani Steels Q2 FY27 Results: Net Profit ₹79.9 Cr, Up 27.8% YoY
Kalyani Steels Ltd reported revenue from operations of ₹494.4 Cr (+8.4% YoY) and net profit of ₹79.9 Cr (+27.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹79.9 Cr · +27.8% YoY
Kalyani Steels Board Meeting Date
Kalyani Steels intimated a Board Meeting scheduled for October 28, 2026 to approve Q2/H1 FY27 unaudited results. Trading window reopens October 31, 2026.
Kalyani Steels Annual General Meeting
Kalyani Steels reported its postal ballot voting results. Shareholders appointed Mr. Ajay Kirtane as Independent Director by requisite majority.
Kalyani Steels Other Announcement
The company filed its quarterly shareholding pattern as per SEBI regulations. This routine disclosure provides the latest break-up of public and promoter equity stakes.
Kalyani Steels Credit Rating
Kalyani Steels Ltd announced that ICRA Limited has reaffirmed and assigned a rating of [ICRA] A1+ for its enhanced Commercial Paper programme of Rs.75 Crore.
- Value
- ₹75.00 Cr
Other adverse business impact announcements
All →Spandana Sphoorty Financial Adverse Business Impact
Cyber fraud debited ₹7.80 crore from Spandana Sphoorty's bank account on November 1, 2026. The company has reported to authorities and filed an insurance claim.
- Value
- ₹7.80 Cr
Medplus Health Services Adverse Business Impact
MedPlus Health Services' subsidiary Optival Health Solutions had its drug licence suspended for five days for a Suryapet store. Expected financial impact is about Rs 1.32 lakh.
- Value
- ₹0.01 Cr
- Execution
- 05 days
Oriental Rail Infrastructure Adverse Business Impact
Oriental Rail's subsidiary Oriental Foundry had a fire at its Kutch plant on 28 October 2026. Damage is minimal, operations are unaffected and the loss is insured.
Capillary Technologies India Adverse Business Impact
Capillary Technologies received KPMG's final forensic report on a cyber-enabled payment fraud at a step-down subsidiary. Four disputed payments totalled EUR 3.04 million, about Rs.32.24 Crore.
- Value
- ₹32.24 Cr
Windlas Biotech Adverse Business Impact
Windlas Biotech disclosed a cyber security incident on 30 October 2026. It states no material impact on core operations, finances or business continuity.
Neogen Chemicals Adverse Business Impact
Neogen Chemicals reports continued fire disruption at MPP3; replacement plant partly built with trial runs underway. Recognized damage totals ₹348.16 crore; production shifted to other sites.
- Value
- ₹348.2 Cr